EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Childhood and adolescent cancer in Germany – an overview

Claudia Spix, Friederike Erdmann, Desiree Grabow, Cécile Ronckers

RKI edoc (Robert Koch-Institut) · 14.06.2023 · 8 (2) · 79-94

DOI: 10.25646/11438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RKI edoc (Robert Koch-Institut), erschienen am 14.06.2023. Verfasst von Claudia Spix und 3 weiteren Autor:innen. Beteiligte Einrichtung: German Childhood Cancer Registry Division of Childhood Cancer Epidemiology Institute of Medical Biostatistics, Epidemiology and Informatics Universit…. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Childhood and adolescent cancer constitutes only a very small fraction of the cancer cases in Germany and throughout the world, but it is the most frequent cause of disease-related death in children. The diagnostic spectrum differs markedly from that of adults. More than 90% of all cases of childhood and adolescent cancer in Germany are treated according to centralised protocols or in therapy studies.

Methods

The main epidemiological data for this group are collected by the German Childhood Cancer Registry (GCCR) since 1980. Based on this data, three typical diagnoses and their incidence and prognosis are described in exemplary manner: Lymphoid leukaemia (LL), astrocytoma and neuroblastoma.

Results

Approximately 2,250 new cancers are diagnosed in children and adolescents under the age of 18 in Germany every year. In this age group, leukaemia and lymphoma account for almost 50% of all new cancer cases, predominately acute forms. Overall, the prognosis is considerably better than in adults.

Conclusions

There is relatively little consistent evidence available on external factors as risk factors for childhood cancer, despite decades of research. For LL, the immune system and infections are assumed to play a role, as early training of the immune system appears to be protective. To an increasing degree, research is identifying genetic risk factors for many types of childhood and adolescent cancer. The therapy is sometimes very intensive and leads to a variety of late effects for at least 75% of the survivors, which may occur soon after the primary diagnosis, but also decades later.

Schlagwörter

Stichwörter der Autor:innen

ADOLESCENTSCANCERCHILDRENEPIDEMIOLOGYGERMANYLONG-TERM FOLLOW-UPPROGNOSIS

Autor:innen und Institutionen

  • German Childhood Cancer Registry Division of Childhood Cancer Epidemiology Institute of Medical Biostatistics, Epidemiology and Informatics University Medical Center of the Johannes Gutenberg University Mainz.

Zitieren

APA

Spix, C., Erdmann, F., Grabow, D., & Ronckers, C. (2023). Childhood and adolescent cancer in Germany – an overview. RKI edoc (Robert Koch-Institut), 8(2), 79-94. https://doi.org/10.25646/11438

Vancouver

Spix C, Erdmann F, Grabow D, Ronckers C. Childhood and adolescent cancer in Germany – an overview. RKI edoc (Robert Koch-Institut). 2023;8(2):79-94. doi:10.25646/11438

BibTeX
@article{Spix2023,
  author = {Spix, Claudia and Erdmann, Friederike and Grabow, Desiree and Ronckers, Cécile},
  title = {Childhood and adolescent cancer in Germany – an overview},
  journal = {RKI edoc (Robert Koch-Institut)},
  year = {2023},
  volume = {8},
  number = {2},
  pages = {79--94},
  doi = {10.25646/11438}
}
Kostenlos starten →